Colgate-Palmolive Company (NYSE:CL – Get Free Report) CFO Stanley Sutula III sold 97,843 shares of the business’s stock in a transaction dated Wednesday, February 4th. The stock was sold at an average price of $94.27, for a total value of $9,223,659.61. Following the completion of the transaction, the chief financial officer directly owned 55,310 shares of the company’s stock, valued at approximately $5,214,073.70. This trade represents a 63.89% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Colgate-Palmolive Stock Performance
CL stock traded down $0.40 during trading on Friday, reaching $94.48. The stock had a trading volume of 5,789,451 shares, compared to its average volume of 7,896,674. The firm has a market cap of $76.16 billion, a PE ratio of 36.06, a PEG ratio of 4.27 and a beta of 0.29. The company has a current ratio of 0.42, a quick ratio of 0.27 and a debt-to-equity ratio of 5.90. The stock’s 50 day moving average is $81.86 and its two-hundred day moving average is $81.60. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $100.18.
Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The company had revenue of $5.23 billion during the quarter, compared to analyst estimates of $5.13 billion. During the same period in the previous year, the business posted $0.91 earnings per share. The firm’s quarterly revenue was up 5.8% compared to the same quarter last year. As a group, equities analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.
Colgate-Palmolive Dividend Announcement
Analyst Ratings Changes
A number of equities analysts have weighed in on CL shares. Raymond James Financial dropped their price target on shares of Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating for the company in a research report on Monday, October 20th. Piper Sandler increased their price target on Colgate-Palmolive from $88.00 to $96.00 and gave the stock an “overweight” rating in a research note on Friday, January 30th. Citigroup boosted their price objective on Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a research report on Monday. Argus reiterated a “hold” rating on shares of Colgate-Palmolive in a research report on Thursday, December 11th. Finally, Evercore boosted their price target on Colgate-Palmolive from $94.00 to $100.00 and gave the stock an “outperform” rating in a report on Monday. Eleven analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $94.47.
Institutional Investors Weigh In On Colgate-Palmolive
Large investors have recently bought and sold shares of the business. Norges Bank purchased a new stake in shares of Colgate-Palmolive during the 2nd quarter valued at about $960,390,000. Northwestern Mutual Wealth Management Co. increased its stake in Colgate-Palmolive by 8,040.1% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 4,655,987 shares of the company’s stock worth $380,666,000 after acquiring an additional 4,598,789 shares during the last quarter. Schroder Investment Management Group raised its position in Colgate-Palmolive by 242.3% during the second quarter. Schroder Investment Management Group now owns 5,324,115 shares of the company’s stock valued at $483,962,000 after purchasing an additional 3,768,784 shares during the period. Pacer Advisors Inc. lifted its stake in shares of Colgate-Palmolive by 3,052.2% in the 3rd quarter. Pacer Advisors Inc. now owns 2,697,047 shares of the company’s stock valued at $215,602,000 after purchasing an additional 2,611,485 shares during the last quarter. Finally, Diamond Hill Capital Management Inc. increased its position in shares of Colgate-Palmolive by 46.7% during the 3rd quarter. Diamond Hill Capital Management Inc. now owns 8,077,549 shares of the company’s stock valued at $645,719,000 after purchasing an additional 2,572,796 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.
The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- What a Former CIA Agent Knows About the Coming Collapse
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Trade this between 9:30 and 10:45 am EST
- Buy this stock tomorrow?
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
